131 related articles for article (PubMed ID: 22587798)
1. Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer.
He P; Sun H; Jian XX; Chen QH; Chen DL; Liu GT; Wang FP
J Asian Nat Prod Res; 2012; 14(6):564-76. PubMed ID: 22587798
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
Sun YF; Wink M
Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
4. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and MDR inhibitory activity evaluation of derivatives of schizandrin A.
Liang XX; Liu GT; Chen QH; Sun H; Chen DL; Wang FP
J Asian Nat Prod Res; 2010 Jul; 12(7):549-56. PubMed ID: 20628932
[TBL] [Abstract][Full Text] [Related]
7. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.
Liu R; Zhang Y; Chen Y; Qi J; Ren S; Xushi MY; Yang C; Zhu H; Xiong D
J Pharm Sci; 2010 Jul; 99(7):3266-75. PubMed ID: 20112430
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
[TBL] [Abstract][Full Text] [Related]
9. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
11. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
12. Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids.
Fu LW; Deng ZA; Pan QC; Fan W
Anticancer Res; 2001; 21(4A):2273-80. PubMed ID: 11724282
[TBL] [Abstract][Full Text] [Related]
13. Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Sureram S; Senadeera SP; Hongmanee P; Mahidol C; Ruchirawat S; Kittakoop P
Bioorg Med Chem Lett; 2012 Apr; 22(8):2902-5. PubMed ID: 22418278
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
15. Bisbenzylisoquinoline alkaloids and P-glycoprotein function: A structure activity relationship study.
Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
Bioorg Med Chem; 2020 Jun; 28(12):115553. PubMed ID: 32503690
[TBL] [Abstract][Full Text] [Related]
16. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance].
Tian H; Pan QC
Yao Xue Xue Bao; 1997 Apr; 32(4):245-50. PubMed ID: 11499024
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of some taxoids as multidrug resistance modulator.
Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
